Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3231 results

Sort By:

Adaptation of REDCHIP Intervention for the Portuguese Context

Study ID: NCT07201779
Start Date: 2026-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

44

Intervention / Treatment

REDCHiP

Treatment As Usual Control Group

Sponsor

ISPA - University Institute of Psychological, Social and Life Sciences

Source: clinicaltrials.gov

Share:
Add to list

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Study ID: NCT07195682
Start Date: 2025-12-15
End Date: 2031-04-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

125

Intervention / Treatment

BMS-986506

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

Study ID: NCT05602142
Start Date: 2026-02
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

[11C]CPPC PET ligand

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Study ID: NCT07143968
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Resmetirom

Placebo Control

Sponsor

Naga p. Chalasani

Source: clinicaltrials.gov

Share:
Add to list

Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

Study ID: NCT07255820
Start Date: 2026-01-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

126

Intervention / Treatment

Rosuvastatin + Ezetimibe

Bempedoic Acid + Ezetimibe

Rosuvastatin + Ezetimibe + Bempedoic Acid

Sponsor

Bahariya University

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

Study ID: NCT06970496
Start Date: 2025-12-31
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

B019

Sponsor

Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

Study ID: NCT04007276
Start Date: 2026-11-10
End Date: 2036-06-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

brimonidine tartrate ophthalmic solution 0.025%

sterile balanced saline solution

Sponsor

Tulane University

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Study ID: NCT07209189
Start Date: 2026-01-15
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

75

Intervention / Treatment

Toripalimab + Chemotherapy

triplimab

Chemoradiotherapy or radiation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Recovery of Physical Function After Critical Illness In Older Adults

Study ID: NCT07225257
Start Date: 2026-05-31
End Date: 2031-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

University of Kentucky

Source: clinicaltrials.gov

Share:
Add to list

Empathy Training and Its Effect on Maternity Nurses' Communication Skills

Study ID: NCT07248592
Start Date: 2025-12-15
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Maternity Nurse Empathy and Communication Skills Training Program

Sponsor

Mansoura University

Source: clinicaltrials.gov

Share:
Add to list